Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listEstramustine sodium phosphate

Estramustine sodium phosphate

Synonym(s):Estra-1,3,5(10)triene-3,17?-diol 3-[N,N-bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate) sodium salt;Estradiol 3-bis(2-chloroethyl)carbamate 17-(dihydrogen phosphate) sodium salt

  • CAS NO.:52205-73-9
  • Empirical Formula: C23H33Cl2NNaO6P
  • Molecular Weight: 544.38
  • MDL number: MFCD00866320
  • EINECS: 257-735-7
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-07-02 08:55:02
Estramustine sodium phosphate Structural

What is Estramustine sodium phosphate?

Description

Estramustine phosphate is a derivative of estradiol (Item Nos. 20776 | 10006315) that contains a nor-nitrogen mustard group. Estramustine phosphate destabilizes microtubules by binding to microtubule-associated proteins (MAPs) with Kd values of 10 and 15 μM for MAP-1 and MAP-2, respectively. Estramustine induces cell cycle arrest in mitosis at the metaphase stage in DU145 and PC3 prostate cancer cells and induces apoptosis in U87MG human malignant glioma cells. The metabolites of estramustine phosphate have anti-androgenic effects. Formulations containing estramustine phosphate are used in the palliative treatment of prostate cancer.

The Uses of Estramustine sodium phosphate

Estramustine sodium phosphate is binds estradiol receptors irreversibly.

The Uses of Estramustine sodium phosphate

Antineoplastic.

The Uses of Estramustine sodium phosphate

Estramustine phosphate sodium USP (Emcyt) is used to treat Prostatic carcinoma.

What are the applications of Application

Estramustine sodium phosphate is binds estradiol receptors irreversibly

Definition

ChEBI: An organic sodium salt which is the disodium salt of estramustine phosphate.

brand name

Emcyt (Pharmacia & Upjohn).

General Description

Estramustine as the phosphate is available in 140-mg capsulesfor the treatment of prostate cancer. Although originallydesigned as an alkylating agent, it has been shown tobe devoid of alkylating activity and functions as an inhibitorof microtubule function by binding to microtubule associate proteins (MAPs) and also binds to tubulin at a site that isdistinct from that of the vinca alkaloids but thought to partiallyoverlap with that of pacilataxel.The major mechanismby which cells become resistant to the agent involvesincreased efflux, although this is not mediated by Pgp as isthe case with other microtubule inhibitors such as the taxanesand vinca alkaloids. Therefore, the agent does not showcross-resistance with these agents. As an inhibitor of microtubules,it is cell cycle specific acting in the M phase. Theagent is well absorbed upon oral administration with hydrolysisof the water solubilizing phosphate beginning to occurin the GI tract. Metabolism involves the formation of theactive estromustine, which arises from oxidation of the C17alcohol to give the ketone. Additional inactive metabolitesresult from carbamate hydrolysis to give estradiol and estrone.The parent and metabolites are primarily eliminatedin the feces with a terminal elimination half-life of 20 hours.The adverse effects of the agent are nausea and vomiting,which is generally mild but the severity may increase uponprolonged administration. Gynecomastia also commonlyoccurs, and diarrhea may also be seen. Less commonly seeneffects include myelosuppression, skin rash, and cardiovascularabnormalities including CHF.

Properties of Estramustine sodium phosphate

storage temp.  Inert atmosphere,2-8°C
solubility  H2O: soluble50mg/mL
form  A crystalline solid
color  White to off-white
Stability: Hygroscopic, Unstable in Solution
CAS DataBase Reference 52205-73-9(CAS DataBase Reference)

Safety information for Estramustine sodium phosphate

Computed Descriptors for Estramustine sodium phosphate

Related products of tetrahydrofuran

You may like

  • Estramustine Sodium Phosphate 98%
    Estramustine Sodium Phosphate 98%
    View Details
  • 52205-73-9 98%
    52205-73-9 98%
    52205-73-9
    View Details
  • Estramustine phosphate sodium 95% (HPLC) CAS 52205-73-9
    Estramustine phosphate sodium 95% (HPLC) CAS 52205-73-9
    52205-73-9
    View Details
  • Estramustine sodium phosphate CAS 52205-73-9
    Estramustine sodium phosphate CAS 52205-73-9
    52205-73-9
    View Details
  • 1823368-42-8 98%
    1823368-42-8 98%
    1823368-42-8
    View Details
  • 2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    1307449-08-6
    View Details
  • Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%
    Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%
    25408-95-1
    View Details
  • Lithium Clavulanate
    Lithium Clavulanate
    61177-44-4
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.